VITUX PHARMA AS
Operating
Investere og utvikle næringsvirksomhet innen marin bioprospektering.
Produksjon og salg av marine fosfolipider. Forskning og utvikling.
Organization
- CEO
- KW
- Chairman of the board
- KW
- Years since formation
- 23 years
- since Jan 31, 2003
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 24,410
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Annual total result 2025
- 35,925
- NOK
- Total equity 2025
- 1,624,750
- NOK
Last update: Jul 4, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
KW | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
KW | Chairman | - |
CE | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
BM | - | 15.59 % indirectly |
PO 1979 | - | 1.06 % indirectly |
Last update: May 2, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 24,410 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2025: NOK 0Operating profit 2025: NOK -6,147,463Employees: 0
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | 35,925 | 18,945 | 26,324 | -5,108 | -26,916 |
Total assets | 1,624,749 | 1,638,384 | 1,569,880 | 1,562,306 | 1,548,664 |
Total liabilities | 0 | 49,560 | 0 | 18,750 | 0 |
Total equity | 1,624,750 | 1,588,825 | 1,569,880 | 1,543,556 | 1,548,664 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 | 0 |
Total operating costs | 51,656 | 72,060 | 57,466 | 63,961 | 48,058 |
Operating result | -51,656 | -72,060 | -57,466 | -63,961 | -48,058 |
Financial income/costs | 87,581 | 91,005 | 83,790 | 58,853 | 21,142 |
Profit before tax | 35,925 | 18,945 | 26,324 | -5,108 | -26,916 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | 35,925 | 18,945 | 26,324 | -5,108 | -26,916 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 1,613,746 | 1,563,897 | 1,462,314 | 1,470,304 | 865,924 |
Total current assets | 11,003 | 74,487 | 107,566 | 92,002 | 682,740 |
Total assets | 1,624,749 | 1,638,384 | 1,569,880 | 1,562,306 | 1,548,664 |
Short term debt | 0 | 49,560 | 0 | 18,750 | 0 |
Long term debt | 0 | 0 | 0 | 0 | 0 |
Total liabilities | 0 | 49,560 | 0 | 18,750 | 0 |
Contributed capital | 31,168,202 | 31,168,202 | 31,168,202 | 31,168,202 | 31,168,202 |
Retained earnings | -29,543,452 | -29,579,377 | -29,598,322 | -29,624,646 | -29,619,538 |
Total equity | 1,624,750 | 1,588,825 | 1,569,880 | 1,543,556 | 1,548,664 |
Total equity and liabilities | 1,624,750 | 1,638,385 | 1,569,880 | 1,562,306 | 1,548,664 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises